| (in millions $) | 31 Mar 2024 | 30 Sep 2023 | 31 Mar 2023 | 30 Sep 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $72176.8 | $53637.2 | $48801.9 | $48408.3 |
| Short term investments | $129444.2 | $133051.8 | $172328.6 | $114586.5 |
| Net receivables | $40356.3 | $41731.4 | $29632.9 | $27174.8 |
| Inventory | $143028.8 | $148723.7 | $119141.3 | $129412.4 |
| Total current assets | $410655.4 | $403800.9 | $396708.9 | $379612.4 |
| Long term investments | $185785.9 | $156937.2 | $121821.6 | $144731.4 |
| Property, plant & equipment | $268725.9 | $256604.3 | $249766.7 | $244674.1 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $918261.6 | $871370.8 | $858829.8 | $821568.8 |
| Current liabilities | ||||
| Accounts payable | $47978.3 | $46616.4 | $46589.9 | $43676.9 |
| Deferred revenue | ||||
| Short long term debt | $710.6 | $625.7 | $891.8 | $504.4 |
| Total current liabilities | $136904 | $148011.1 | $137394.1 | $133296.9 |
| Long term debt | $2323.7 | $2214.9 | $2168.6 | $2022.2 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $169361.9 | $175057.7 | $163441.9 | $160242.9 |
| Shareholders' equity | ||||
| Retained earnings | $543838.3 | $535436.9 | ||
| Other shareholder equity | $736415 | $683842.2 | $682959.9 | $648926.7 |
| Total shareholder equity | $748899.7 | $696313.1 | $695387.9 | $661325.9 |
| (in millions $) | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $72176.8 | $48801.9 | $46544.2 | $2904.2 |
| Short term investments | $129444.2 | $172328.6 | $148296.9 | $196075.1 |
| Net receivables | $40356.3 | $29632.9 | $24686.7 | $34257 |
| Inventory | $141528.8 | $119141.3 | $108641.5 | $105072.2 |
| Total current assets | $410655.4 | $396708.9 | $342324.5 | $349919.9 |
| Long term investments | $185785.9 | $121821.6 | $145305.1 | $105029.7 |
| Property, plant & equipment | $268725.9 | $249766.7 | $242730.1 | $241355.8 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $918261.6 | $858829.8 | $772595.5 | $738193 |
| Current liabilities | ||||
| Accounts payable | $47978.3 | $46589.9 | $44172.6 | $43187.3 |
| Deferred revenue | ||||
| Short long term debt | $710.6 | $891.8 | $509.2 | $585.9 |
| Total current liabilities | $136904 | $137394.1 | $121637.1 | $106896.8 |
| Long term debt | $2323.7 | $2168.6 | $1985.2 | $2125.4 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $169361.9 | $163441.9 | $148039.8 | $134719.6 |
| Shareholders' equity | ||||
| Retained earnings | $543838.3 | $535436.9 | $612232.4 | $492977.8 |
| Other shareholder equity | $736415 | $682959.9 | $21424 | $2358.7 |
| Total shareholder equity | $748899.7 | $695387.9 | $624555.7 | $603473.4 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $184573.3 | $179227 | $180193.7 | $177744.7 |
| Cost of revenue | $72837.3 | $65870.4 | $70418.5 | $70686.7 |
| Gross Profit | $111736 | $113356.6 | $109775.2 | $107058 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $16729.4 | $15579.5 | $15863.9 | $15078.7 |
| Total operating expenses | $122074.9 | $117579.2 | $119750 | $117732.7 |
| Operating income | $62498.4 | $61647.8 | $60443.7 | $60012 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $17610.6 | $16467.5 | $12815.7 | $17003.1 |
| Interest expense | -$112.5 | -$125.9 | -$136 | -$98.7 |
| Net income | ||||
| Net income | $50915.9 | $51205.5 | $53352.3 | $48980.7 |
| Income (for common shares) | $50915.9 | $51205.5 | $53352.3 | $48980.7 |
| (in millions $) | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $708810 | $709368.5 | $652049.6 | $531551.2 |
| Cost of revenue | $272472.1 | $290057.7 | $309219.4 | $250236.7 |
| Gross Profit | $436337.9 | $419310.8 | $342830.2 | $281314.5 |
| Operating activities | ||||
| Research & development | $460.3 | |||
| Selling, general & administrative | $61343.5 | $57362.2 | $48905.5 | $100026.3 |
| Total operating expenses | $464430.4 | $470809.3 | $462789.6 | $377424 |
| Operating income | $244379.6 | $238559.2 | $189260 | $154127.2 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $63885.2 | $64384 | $52373.4 | $45552.9 |
| Interest expense | -$459.6 | -$432 | $82.6 | |
| Net income | ||||
| Net income | $204587.8 | $191916.6 | $152426.6 | $131611.9 |
| Income (for common shares) | $204587.8 | $191916.6 | $152426.6 | $131611.9 |
| (in millions $) | 31 Mar 2022 | 30 Sep 2021 | 31 Mar 2021 | 30 Sep 2020 |
|---|---|---|---|---|
| Net income | $112149.1 | -$84126.1 | $179381.7 | $79916.7 |
| Operating activities | ||||
| Depreciation | $8965.5 | -$8097.3 | $16455.9 | $8235.9 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $99542 | -$67627.3 | $125840.4 | $44650.8 |
| Investing activities | ||||
| Capital expenditures | -$11711.2 | $8661.2 | -$18366.4 | -$8872.5 |
| Investments | ||||
| Total cash flows from investing | -$32890.4 | -$46323.6 | $56829.1 | $65371.8 |
| Financing activities | ||||
| Dividends paid | -$67107.3 | $118038 | -$188813.9 | -$115210.1 |
| Sale and purchase of stock | $621.2 | -$612.9 | $2906.5 | $2145.8 |
| Net borrowings | -$303.2 | $279.6 | -$570.1 | -$171 |
| Total cash flows from financing | -$66840.9 | $117374.2 | -$186338.3 | -$113090.1 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$189.3 | $3423.3 | -$3668.8 | -$3067.5 |
| (in millions $) | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Net income | $204587.8 | $191916.6 | $207404.7 | $179381.7 |
| Operating activities | ||||
| Depreciation | $18163.9 | $18090.1 | $17324.1 | $16455.9 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $171788.6 | $188775.5 | $157755.1 | $125840.4 |
| Investing activities | ||||
| Capital expenditures | -$35625.3 | -$27429.9 | -$21416.4 | -$18366.4 |
| Investments | ||||
| Total cash flows from investing | $15627.7 | -$57322.9 | -$22384.9 | $56829.1 |
| Financing activities | ||||
| Dividends paid | -$198992 | -$154175.3 | -$137883.2 | -$188813.9 |
| Sale and purchase of stock | $14428.3 | $24773.9 | $2914.8 | $2906.5 |
| Net borrowings | -$604.6 | -$598.4 | -$593.7 | -$570.1 |
| Total cash flows from financing | -$185509.6 | -$130060.3 | -$135805 | -$186338.3 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1906.7 | $1392.3 | -$434.8 | -$3668.8 |
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $721.74B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $204.45B |
| Revenue Q/Q | 7.53% |
| Revenue Y/Y | 3.68% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 23.57% |
| ROE | 29.19% |
| Debt/Equity | 0.23 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.00 |
| Quick ratio | 1.95 |